Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred J Saah

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Vaccine|January 15, 2019
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-upWen Chen, Yun Zhao, Xing Xie, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasmaDavid W Haas, Benjamin Johnson, Janet Nicotera, et al.
Expert Review of Vaccines|September 30, 2022
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature reviewWei Vivian Wang, Smita Kothari, Jozica Skufca, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 10, 2013
Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black womenLiana R Clark, Evan R Myers, Warner Huh, et al.
The Journal of Infectious Diseases|March 28, 2003
Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapyAlfred J Saah, David W Haas, Mark J DiNubile, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 16, 2004
Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individualsEdward P Acosta, Hulin Wu, Scott M Hammer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic CountriesSusanne K Kjaer, Mari Nygård, Joakim Dillner, et al.
The Pediatric Infectious Disease Journal|June 25, 2015
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015Michelle Vichnin, Paolo Bonanni, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2016
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world ExperienceSuzanne M Garland, Susanne K Kjaer, Nubia Muñoz, et al.
International Journal of Cancer|April 15, 2011
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionRichard M Haupt, Cosette M Wheeler, Darron R Brown, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Vaccine|January 15, 2019
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-upWen Chen, Yun Zhao, Xing Xie, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasmaDavid W Haas, Benjamin Johnson, Janet Nicotera, et al.
Expert Review of Vaccines|September 30, 2022
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature reviewWei Vivian Wang, Smita Kothari, Jozica Skufca, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 10, 2013
Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black womenLiana R Clark, Evan R Myers, Warner Huh, et al.
The Journal of Infectious Diseases|March 28, 2003
Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapyAlfred J Saah, David W Haas, Mark J DiNubile, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 16, 2004
Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individualsEdward P Acosta, Hulin Wu, Scott M Hammer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic CountriesSusanne K Kjaer, Mari Nygård, Joakim Dillner, et al.
The Pediatric Infectious Disease Journal|June 25, 2015
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015Michelle Vichnin, Paolo Bonanni, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2016
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world ExperienceSuzanne M Garland, Susanne K Kjaer, Nubia Muñoz, et al.
International Journal of Cancer|April 15, 2011
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionRichard M Haupt, Cosette M Wheeler, Darron R Brown, et al.
Pageof 3